Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulfate as an Adjuvant to Bupivacaine in Local Wound Infiltration for MRM
NCT07789600Not yet recruiting
- Sponsor
- King Hussein Cancer Center
- Start
- Sep 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Randomised, double-blind trial of magnesium sulfate in postoperative pain (2 arms), sponsored by King Hussein Cancer Center. Primary endpoint: Overall Postoperative Pain Burden During the First 24 Hours After Surgery. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
magnesium sulfate
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07789600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07789600.